Pharmaceutical Analysis & Statistics in Oceania Countries, July 2014 (p3)

61-90 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

Adult Mouth Care in New Zealand

Adult Mouth Care in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Grocery retailers, in particular supermarkets began to play a larger role within adult mouth care in New Zealand over the latter half of the review period. In fact, supermarkets accounted for 21% share ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Sports Nutrition in New Zealand

Sports Nutrition in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

As health and wellness trends continued to dominate the New Zealand landscape, sports nutrition continued to remain popular within the country during 2013. Moreover, New Zealand consumers are considered ...

  • Industries : Healthcare
  • Countries : New Zealand
NRT Smoking Cessation Aids in New Zealand

NRT Smoking Cessation Aids in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Every year in January, specific tax rates on tobacco are adjusted for movements in the Consumer Price Index (CPI). Furthermore, in early 2010, the New Zealand government swiftly introduced a raft of new ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Weight Management in New Zealand

Weight Management in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

According to Euromonitor International, 33% of the New Zealand population (those adults aged 15 years and older) were obese (body mass index of 30 and over) during 2013. The obesity rate among men was ...

  • Industries : Healthcare
  • Countries : New Zealand
Consumer Health in New Zealand

Consumer Health in New Zealand

  • $ 2 394
  • Industry report
  • July 2014
  • by Euromonitor International

Over 2013, value sales of consumer health in New Zealand grew as a result of growing consumer confidence, which was boosted by the genesis of the Christchurch rebuild, as New Zealand’s economy finally ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Analgesics in New Zealand

Analgesics in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Nuromol was launched by Reckitt Benckiser New Zealand Ltd in September 2011. The product contains 200mg of ibuprofen and 500mg of acetaminophen. The brand performed well, with value sales increasing by ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand

Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Consumer demand for seasonal cold/flu ailments kept cough, cold and allergy (hay fever) remedies buoyant during 2013. Products are available throughout the year, but are most likely to be purchased during ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Digestive Remedies in New Zealand

Digestive Remedies in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

During 2013, value sales growth for digestive remedies continued to be positive as consumers dealt with the negative flow-on effects of changing dietary habits, busy working lifestyles and less exercise. ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Vitamins and Dietary Supplements in New Zealand

Vitamins and Dietary Supplements in New Zealand

  • $ 898
  • Industry report
  • July 2014
  • by Euromonitor International

Vitamins and dietary supplements remained important within New Zealand during 2013 as consumers continued to be concerned with health and wellness issues. Consumers continued to shift towards prevention, ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement
  • Countries : New Zealand
Pharmacybrands Ltd in Consumer Health (New Zealand)

Pharmacybrands Ltd in Consumer Health (New Zealand)

  • $ 153
  • Company report
  • July 2014
  • by Euromonitor International

Pharmacybrands Ltd is expected to continue expanding its retail network of chemists/pharmacies across New Zealand through its five banners; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. ...

  • Countries : New Zealand
Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

Pain Medication OTC Manufacturing in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

Growth pains: Tighter regulatory controls constrain industry revenue growth Pain Medication OTC Manufacturing in Australia Companies in this industry research and develop over-the-counter pain relief ...

  • Industries : Drug and Medication
  • Countries : Australia
QRxPharma Limited - Product Pipeline Review - 2014

QRxPharma Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

QRxPharma Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘QRxPharma Limited - Product Pipeline Review - 2014’, provides an overview of the QRxPharma Limited’s pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : China, World, Australia
Australian Pharmaceutical Industries Ltd in Beauty and Personal Care (Australia)

Australian Pharmaceutical Industries Ltd in Beauty and Personal Care (Australia)

  • $ 153
  • Company report
  • June 2014
  • by Euromonitor International

Australian Pharmaceutical Industries Ltd’s strategy involves the rapid expansion of its Priceline Pharmacy portfolio of stores while maintaining its strong position in the community pharmacy wholesale ...

  • Industries : Pharmaceutical
  • Countries : Australia
Global Skincare Market: Merger and Acquisitions May 2014

Global Skincare Market: Merger and Acquisitions May 2014

  • $ 295
  • Industry report
  • June 2014
  • by Canadean Ltd

Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during May 2014. Summary Using ...

  • Industries : Skin Care
  • Countries : United States, New Zealand, World
Physiotherapy Services in Australia - Industry Market Research Report

Physiotherapy Services in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

Picture of health: An ageing population and specialisation trends support revenue growth Physiotherapy Services in Australia This industry is made up of companies and practitioners that primarily provide ...

  • Industries : Therapy
  • Countries : Australia
Sigma Pharmaceuticals Ltd in Retailing (Australia)

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : Pharmaceutical
  • Countries : Australia
PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market ...

  • Industries : Drug and Medication
  • Countries : Australia
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication, Pathology
  • Countries : World, Australia, Japan
Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Drug and Medication
  • Countries : World, Australia
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : World, Australia, Japan
Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Drug and Medication
  • Countries : Australia, World
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World, Australia
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : World, Australia

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.